Zhejiang Jolly Pharmaceutical Co., Ltd.
佐力药业
300181
Shenzhen Stock Exchange
Company Overview
Zhejiang Jolly Pharmaceutical Co., Ltd. is a national high-tech pharmaceutical enterprise founded in January 2000 and listed on the ChiNext board of the Shenzhen Stock Exchange in February 2011. The company is located in the Moganshan Economic Development Zone of Zhejiang Province and spans over 260 acres, with a construction area exceeding 150,000 square meters. Jolly Pharmaceutical integrates scientific research, production, and sales, and has been recognized with various honors, including "High and New Technology Enterprise" and "National Green Factory." The company's primary focus is on the development and production of traditional Chinese medicine and related products, including the Wuling series, Bai Ling series, and various forms of Chinese medicine tablets and granules. Notably, Wuling powder and Wuling capsules are classified as Class I new drugs of traditional Chinese medicine, with specific applications for conditions such as depression and anxiety. Jolly Pharmaceutical emphasizes innovation in its product development and has established a comprehensive marketing strategy, supported by a strong research and development team recognized at both provincial and national levels.
AI-generated from company disclosures and CNInfo data.
Company Profile
1、 Product advantage: Wuling powder is a new drug of the National Class I Traditional Chinese Medicine, and the company's proprietary technology - "key technology of industrialized production of rare medicinal fungus Wuling and its clinical application" was jointly issued by the Ministry of Science and Technology and the State Secrets Bureau in February 2010, and has obtained the certificate of secret technology. The company extends the strategy of developing series of products around the powder of Wuling fungus and builds up a product line with independent intellectual property rights, and Wuling capsules, Lingze tablets and Linglian granules are all exclusive products. 2、 Brand Advantage: Since its establishment, the company has built up a good brand image among patients around the exclusive product advantages of Wuling series. The company's Wuling capsules and Bailing tablets have been honored on the list of China's non-prescription drug manufacturers and products in the comprehensive statistical ranking for many times. 3、Marketing Advantage: The company has formulated a marketing strategy in line with the company's development by focusing on the strategic goal of "one body, two wings", and has continued to promote the construction of the marketing system.The company has professional self-management, investment promotion and OTC sales teams, and has established a refined marketing network in the hospital market, primary care market, retail market and Internet e-commerce platform, focusing on academic marketing and brand marketing. 4、R&D Advantage : The company has cultivated and created a biomedical innovation team with complete professional configuration, reasonable age structure, rich working experience, strong sense of innovation, good professional ethics and complete professional qualifications. The company's R&D center has been recognized as Zhejiang Provincial Enterprise Technology Center, Provincial High-tech Research and Development Center, State Local Joint Engineering Laboratory of Pharmaceutical Technology for Medicinal Fungi, and Provincial Enterprise Research Institute.
Key Financials
Announcements
Notes & Comments
Sign in to leave a comment or private note.
No notes or comments yet.